BerandaAKUMS • NSE
add
Akums Drugs and Pharmaceuticals Ltd
Tutup sebelumnya
₹529,95
Rentang hari
₹510,00 - ₹543,00
Rentang tahun
₹405,00 - ₹1.175,90
Kapitalisasi pasar
81,22Â M INR
Volume Rata-Rata
438,94Â rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
NSE
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (INR) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 10,10Â M | -6,69% |
Biaya operasional | 3,31Â M | 4,68% |
Laba bersih | 651,82Â jt | -66,35% |
Margin laba bersih | 6,45 | -63,95% |
Penghasilan per saham | — | — |
EBITDA | 1,05Â M | -0,66% |
Tarif pajak efektif | 27,17% | — |
Neraca
Total aset
Total liabilitas
| (INR) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 7,95 M | — |
Total aset | — | — |
Total liabilitas | — | — |
Total ekuitas | 28,47 M | — |
Saham yang beredar | 153,01 jt | — |
Harga terhadap nilai buku | 2,79 | — |
Tingkat pengembalian aset | — | — |
Tingkat pengembalian modal | 5,69% | — |
Arus Kas
Perubahan kas bersih
| (INR) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 651,82Â jt | -66,35% |
Kas dari operasi | — | — |
Kas dari investasi | — | — |
Kas dari pembiayaan | — | — |
Perubahan kas bersih | — | — |
Arus kas bebas | — | — |
Tentang
Akums Drugs and Pharmaceuticals Limited is an Indian pharmaceutical Contract Development and Manufacturing Organization that serves both domestic and multinational pharmaceutical companies. The company was established in 2004 and became publicly listed on 6 August 2024.
Akums is India's largest Contract Development and Manufacturing Organization, driving pharmaceutical innovation and excellence in the Indian Pharmaceutical Market. From inception it has developed over 4,100 commercialized formulations across 60+ dosage forms, catering to key therapeutic areas such as cardio-diabetes, neurology, gynecology, nephrology, anti-infectives, respiratory, analgesics, and multi-vitamins. Our robust R&D capabilities have led to 220+ innovative formulations, supported by 22+ versatile platform technologies that enhance product development and differentiation. Wikipedia
Didirikan
2004
Situs
Karyawan
7.388
